Loading clinical trials...
Loading clinical trials...
Home-based Transcranial Direct-current Stimulation (tDCS) for Prevention of Suicidal Ideation
Risk for suicide is elevated in the period after discharge from hospital among adults with major affective disorder. The primary objective of this study is to investigate the feasibility of delivering tDCS sessions for high-risk patients for suicide at home in the days following discharge from an emergency department or inpatient unit. This is a single-center, randomized, sham-controlled, double-blind clinical study. We plan to assess up to 80 adult patients for eligibility over 12 months of which 20 will be enrolled and randomized. Clinical assessments will be performed at baseline, post-treatment day 14 (14 days after the first tDCS session), and follow-up day 30 and 60 (30 and 60 days after the first tDCS session, respectively).
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
University of Rochester
Rochester, New York, United States
Start Date
September 21, 2023
Primary Completion Date
April 24, 2024
Completion Date
June 11, 2024
Last Updated
February 6, 2026
33
ACTUAL participants
Home-based transcranial direct current stimulation (tDCS)
DEVICE
Sham home-based transcranial direct current stimulation (tDCS)
DEVICE
Lead Sponsor
University of Rochester
Collaborators
NCT07025720
NCT07432438
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions